Cahill Represents Lead Arrangers in Jazz Financing Lux’s $1.895 Billion Credit Facility

September 23, 2026

Cahill represented the lead arrangers in connection with a $1.895 billion refinancing and maturity extension amendment to the term loan credit agreement for Jazz Financing Lux.

Proceeds from the credit facility were used to refinance existing credit.

Jazz Pharmaceuticals is a global biopharmaceutical company with a patient-focused and science-driven approach aimed at transforming the lives of their patients and families.